Kawthar Diab | Life Science | Best Researcher Award

Kawthar Diab | Life Science | Best Researcher Award

Prof. Dr. Kawthar Diab, National Research Centre, Egypt.

Dr. Kawthar Abdelaziz Elsayed Mohamed Diab is a distinguished Research Professor in Genetics and Cytology at the National Research Centre, Cairo, Egypt. With a strong foundation in zoology, she pursued advanced degrees focusing on genotoxicity, cytogenetics, and medicinal plant applications in disease prevention. Her postdoctoral research at Tokai University, Japan, and the Indian Institute of Integrative Medicine, India, expanded her expertise in cancer pharmacology and bioscience. Dr. Diab has made significant contributions to genetic toxicology and the chemopreventive properties of medicinal plants, with a particular focus on the Lamiaceae family and Himalayan plants. She actively mentors Ph.D. students and collaborates on groundbreaking research projects, gaining international recognition through conferences and workshops.

Profile

Google Scholar

Scopus

🌱 Early Academic Pursuits

Kawthar Abdelaziz Elsayed Mohamed Diab embarked on her academic journey with a deep passion for zoology, earning her B.Sc. in Zoology from Al-Azhar University in 1996 with a distinguished grade of “Very Good.” She further honed her expertise by obtaining an M.Sc. in Experimental Zoology from Zagazig University in 2003, where she conducted cytogenetic and immunogenetic studies on the effects of chemotherapy drugs on reproduction. Her academic curiosity and dedication led her to pursue a Ph.D. in Zoology at Ain Shams University, awarded in 2009. Her doctoral research focused on the protective effects of medicinal plants against genotoxic damage induced by hydrocortisone in mice, marking the beginning of her lifelong commitment to genetic research and cytology.

🧬 Professional Endeavors

As a Research Professor at the Genetics and Cytology Department of the National Research Centre in Cairo, Egypt, Dr. Kawthar Diab has played a pivotal role in advancing genetic studies. Her postdoctoral fellowships further expanded her scientific horizons—first in Cancer Pharmacology at the Indian Institute of Integrative Medicine in 2012 and later in Bioscience at Tokai University, Japan, in 2014. These international research experiences enriched her expertise in genetic applications, cytogenetics, and pharmacogenomics. Her relentless pursuit of knowledge has positioned her as a leading researcher in genetic and cytological studies, bridging traditional knowledge with cutting-edge scientific advancements.

🌿 Contributions and Research Focus

Dr. Diab’s research delves into the genotoxicity of pharmaceutical compounds and the protective effects of medicinal plants. Her investigations focus on the genetic impact of chemotherapy drugs and natural therapeutic agents, particularly those derived from the Lamiaceae family, known for their biochemical and therapeutic properties. Her recent supervision of Ph.D. research on biochemical and therapeutic evaluations of medicinal plants for prostate diseases underscores her commitment to integrating molecular genetics with natural medicine. Additionally, her work on cancer chemoprevention using Himalayan plants has gained international recognition, reflecting her dedication to discovering novel plant-based remedies for serious health conditions.

🌍 Accolades and Recognition

Dr. Kawthar Diab’s expertise has been acknowledged on the global stage. She was invited as a speaker at the 6th Rajabhat University National and International Research and Academic Conference (2020), where she presented her groundbreaking research on cancer chemopreventive activity of Himalayan plants. She has also participated in esteemed international workshops, including the Fluorescence Microscopy Workshop at ICGEB, New Delhi (2019), further enhancing her methodological skills. These recognitions highlight her contributions to genetic research and her growing influence in the scientific community.

đź“– Impact and Influence

Beyond her research, Dr. Diab is actively shaping the next generation of scientists. She mentors young researchers, including Ph.D. students working on innovative projects in pharmacogenomics and plant-based medicine. Her collaboration with interdisciplinary teams ensures that her work extends beyond academic publications, making real-world contributions to medical science and genetics. By fostering a culture of inquiry and scientific exploration, she continues to inspire budding researchers to explore the genetic foundations of disease prevention and treatment.

🔬 Legacy and Future Contributions

With a research portfolio spanning genetic toxicology, medicinal plant applications, and cytogenetics, Dr. Kawthar Diab’s legacy is firmly established in the scientific world. She envisions a future where genetic research and plant-based therapeutics converge to provide safer, more effective treatments for cancer and genetic disorders. Her continuous engagement with international scientific platforms and her mentorship of emerging scholars ensure that her influence will extend far beyond her own research, shaping the future of genetic and cytological studies.

Publication

  • Title: In Vitro Anticancer Activities of Anogeissus latifolia, Terminalia bellerica, Acacia catechu and Moringa oleifera Indian Plants
    Author: KAE Diab, SK Guru, S Bhushan, AK Saxena
    Year: 2015

 

  • Title: In vitro studies on phytochemical content, antioxidant, anticancer, immunomodulatory, and antigenotoxic activities of lemon, grapefruit, and mandarin citrus peels
    Author: KAE Diab
    Year: 2016

 

  • Title: In vivo comparative studies on antigenotoxicity of date palm (Phoenix dactylifera L.) pits extract against DNA damage induced by N-Nitroso-N-methylurea in mice
    Author: KA Diab, EI Aboul-Ela
    Year: 2012

 

  • Title: Carbon tetrachloride induced hepato/renal toxicity in experimental mice: antioxidant potential of Egyptian Salvia officinalis L essential oil
    Author: MA Fahmy, KA Diab, NS Abdel-Samie, EA Omara, ZM Hassan
    Year: 2018

 

  • Title: Genotoxicity of carbon tetrachloride and the protective role of essential oil of Salvia officinalis L. in mice using chromosomal aberration, micronuclei formation, and …
    Author: KAE Diab, MA Fahmy, ZM Hassan, EM Hassan, AB Salama, EA Omara
    Year: 2018

 

  • Title: Inhibitory activity of black mulberry (Morus nigra) extract against testicular, liver and kidney toxicity induced by paracetamol in mice
    Author: KA Diab, MA Fahmy, EM Hassan, ZM Hassan, EA Omara, …
    Year: 2020

 

  • Title: The impact of the low frequency of the electromagnetic field on human
    Author: KA Diab
    Year: 2020

 

  • Title: Inhibitory activity of flaxseed oil against CdCl2 induced liver and kidney damage: Histopathology, genotoxicity, and gene expression study
    Author: KA Diab, NE Ibrahim, MA Fahmy, EM Hassan, EA Omara
    Year: 2020

🏆 Conclusion

Dr. Kawthar Diab’s journey from an aspiring zoologist to a distinguished Research Professor in Genetics and Cytology is a testament to her unwavering commitment to scientific discovery. Her work not only enhances our understanding of genetic toxicology but also paves the way for integrating traditional medicinal knowledge with modern genetic research. As she continues to push the boundaries of genetic science, her contributions remain invaluable to both academia and global health advancements.

Baoying Huang | Pathogen Biology | Best Researcher Award

Baoying Huang | Pathogen Biology | Best Researcher Award

Ms. Baoying Huang,  National Institute for Viral Disease Control and Prevention, China.

Dr. Baoying Huang, a distinguished professor at the Biotech Center for Viral Disease Emergency, China CDC, has over two decades of experience in combating viral diseases. Her expertise lies in vaccine and antiviral drug development for emerging and re-emerging infectious diseases, including COVID-19, monkeypox, and other human coronaviruses.

 

profile

Scopus

🎓 Education Experience

2008.09–2011.07: Doctor of Medicine, Pathogen Biology,Biotech Center for Viral Disease Emergency, China CDC.2005.09–2008.07: Master of Biology, Pathogen Biology,Biotech Center for Viral Disease Emergency, China CDC. 2001.09–2005.07: Bachelor of Biology,
Life Science Department, Nan Hua University, China.

👩‍🔬 Professional Experience

2020.07–Present:  Professor, China CD ,Focus: Vaccine and antiviral drug R&D for SARS-CoV-2 and poxvirus diseases, including COVID-19 and monkeypox. Key Role: Participated in COVID-19 Emergency Projects for SARS-CoV-2 variant monitoring in China.2015.07–2020.07:  Associate Professor, China CDC. Focus: Vaccine and antiviral drug R&D for emerging infectious diseases like influenza and coronaviruses (SARS-CoV, MERS-CoV).2015.04–2015.06:  Assistant Professor, China CDC. Global Health Support Program: Worked in Sierra Leone to establish Ebola lab systems, improving public health infrastructure.2011.07–2015.07: Assistant Professor, China CDC. Focus: Pathogenic molecular mechanisms of influenza viruses, pseudo-virus applications, and gene-engineered vaccines. 2005.09–2011.07:  Graduate Researcher, IVDC, China CDC. Specialization: Developing universal influenza vaccines for cross-protection against various strains.

🔬 Research Focus

Baoying Huang’s work is dedicated to:Vaccine Development: COVID-19 vaccines (BBIBP-CorV, mRNA vaccines) and pan-orthopoxvirus solutions.Emerging Diseases: Countermeasures for SARS-CoV-2, monkeypox, and other viral threats.Diagnostics: Whole-genome sequencing and real-time PCR for virus detection and monitoring.Therapeutics: Screening novel antivirals targeting viruses like SARS-CoV-2 and monkeypox.Key achievements include:Leading the development of Sinopharm COVID-19 vaccine, later approved by WHO for Emergency Use Listing.Establishing monitoring systems for SARS-CoV-2 variants and assessing their impact on public health measures. Advancing monkeypox vaccine research and identifying promising antiviral compounds against orthopoxviruses.

📚 Publications

  • Title: Molecular architecture of monkeypox mature virus
    • Authors: Hong, Y., Huang, B., Zhang, J., Tan, W., Li, S.
    • Year: 2024

 

  • Title: Vaccinia virus Tiantan strain blocks host antiviral innate immunity and programmed cell death by disrupting gene expression
    • Authors: Wu, C., Zhang, Z., Li, Z., Deng, Y., Tan, W.
    • Year: 2024

 

  • Title: A clinically used anti-human papilloma virus agent (3-hydroxyphthalic anhydride-modified bovine β-lactoglobulin) has a potential for topical application to prevent sexual transmission of monkeypox virus
    • Authors: Sha, Y., Huang, B., Hua, C., Tan, W., Jiang, S.
    • Year: 2024

 

  • Title: Development of a multiplex real-time PCR assay for the simultaneous detection of mpox virus and orthopoxvirus infections
    • Authors: Fan, Z., Xie, Y., Huang, B., Tan, W., Guo, F.
    • Year: 2024

 

  • Title: Accurate determination of the whole genome sequencing and open reading frames composition of non-replicating Tiantan strain of vaccinia virus based on novel long read sequencing platform
    • Authors: Zhang, Z., Wu, C., Li, H., Huang, B., Tan, W.
    • Year: 2024

 

  • Title: Characterization of whole genomes from recently emerging Mpox cases in several regions of China, 2023
    • Authors: Wu, C., Cui, L., Pan, Y., Wang, Q., Tan, W.
    • Year: 2024

 

  • Title: Intranasal immunization with single-dose vaccine based on recombinant influenza virus H1N1 expressing the extracellular domain of respiratory syncytial virus G protein induces robust immunity and protection in mice
    • Authors: Han, R., Wang, D., Wang, T., Huang, B., Tan, W.
    • Year: 2024

 

  • Title: Rapid identification of full-length genome and tracing variations of monkeypox virus in clinical specimens based on mNGS and amplicon sequencing
    • Authors: Wu, C., A, R., Ye, S., Lu, J., Tan, W.
    • Year: 2024

 

  • Title: Long-lasting humoral and cellular memory immunity to vaccinia virus Tiantan provides pre-existing immunity against mpox virus in Chinese population
    • Authors: Li, M., Guo, Y., Deng, Y., Gao, G.F., Liu, J.
    • Year: 2024

 

  • Title: Identification of the VP37 pocket of monkeypox virus as a promising target for pan-orthopoxvirus inhibitors through virtual screening and antiviral assays
    • Authors: Huo, S., Wu, L., Huang, B., Xu, Z., Tan, W.
    • Year: 2024

 

Conclusion

Dr. Huang’s career exemplifies unwavering dedication to improving public health through innovation in vaccine development, antiviral research, and diagnostic technologies. Her contributions to tackling global health challenges, such as the COVID-19 pandemic and monkeypox outbreaks, have significantly impacted infectious disease prevention and control worldwide. As viruses continue to evolve, her pioneering work remains a cornerstone in safeguarding global health.